» Articles » PMID: 2920638

Perforation of Esophagus After Endoscopic Variceal Sclerotherapy. Incidence and Clues to Pathogenesis

Overview
Journal Dig Dis Sci
Specialty Gastroenterology
Date 1989 Mar 1
PMID 2920638
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

To determine the true incidence of endoscopic variceal sclerotherapy (EVS)-related esophageal perforation, a retrospective analysis of 900 EVS procedures using sodium tetradecyl sulfate performed on 170 patients during a five-year period (1980-1985) was carried out. Autopsy data of all patients who received EVS and who died (32 patients, 100%) during this period were available to confirm the diagnosis of perforation. Esophageal perforation was confirmed in 5 (2.9%) and was seen in patients with advanced alcoholic liver disease. Importantly, most patients did not manifest features of an esophageal leak, but presented instead as a deterioration in condition and died after a mean (+/- SD) 14 +/- 5.2 days. Analysis of the clinical and EVS data reveals that the risk of developing perforation is high when EVS is performed during active bleeding. The extravariceal location of sclerosant and microabscesses may be important predisposing factors. In our experience large-dose injection, deep ulceration, and balloon tamponade are less likely predisposing factors of this complication.

Citing Articles

The insidious presentation and challenging management of esophageal perforation following diagnostic and therapeutic interventions.

Lampridis S, Mitsos S, Hayward M, Lawrence D, Panagiotopoulos N J Thorac Dis. 2020; 12(5):2724-2734.

PMID: 32642181 PMC: 7330325. DOI: 10.21037/jtd-19-4096.


Delayed esophagopleural fistula after endoscopic injection sclerotherapy for esophageal varices: A case report.

Sui M, Tang W, Wu C, Yang J, Liu H, Huang C Medicine (Baltimore). 2020; 99(3):e18806.

PMID: 32011485 PMC: 7220033. DOI: 10.1097/MD.0000000000018806.


Doppler ultrasound could predict varices progression and rebleeding after portal hypertension surgery: lessons from 146 EGDS and 10 years of follow-up.

Ferreira F, Ribeiro M, Santos M, Assef J, Szutan L World J Surg. 2009; 33(10):2136-43.

PMID: 19672648 DOI: 10.1007/s00268-009-0196-y.


Effects of endoscopic variceal ligation in lower esophageal motor function: a prospective study.

Kim H, Song J, Kim H, Choi S, Lyou J, Kim T Korean J Intern Med. 1995; 10(2):120-4.

PMID: 7495769 PMC: 4532049. DOI: 10.3904/kjim.1995.10.2.120.


Frequent endoscopic variceal sclerotherapy increases risk of complications. Prospective randomized controlled study of two treatment schedules.

Akriviadis E, Korula J, Gupta S, Ko Y, Yamada S Dig Dis Sci. 1989; 34(7):1068-74.

PMID: 2787232 DOI: 10.1007/BF01536376.


References
1.
Korula J, BALART L, Radvan G, Zweiban B, Larson A, Kao H . A prospective, randomized controlled trial of chronic esophageal variceal sclerotherapy. Hepatology. 1985; 5(4):584-9. DOI: 10.1002/hep.1840050410. View

2.
Barsoum M, Bolous F, Ramzy A, Mahmoud F . The complications of injection sclerotherapy of bleeding oesophageal varices. Br J Surg. 1982; 69(2):79-81. DOI: 10.1002/bjs.1800690207. View

3.
Carr-Locke D, Sidky K . Broncho-oesophageal fistula: a late complication of endoscopic variceal sclerotherapy. Gut. 1982; 23(11):1005-7. PMC: 1419802. DOI: 10.1136/gut.23.11.1005. View

4.
Korula J . Pseudotumor of the esophagus: an unusual complication of esophageal variceal sclerotherapy. Am J Gastroenterol. 1985; 80(12):954-6. View

5.
. Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial. N Engl J Med. 1984; 311(25):1594-600. DOI: 10.1056/NEJM198412203112502. View